Kim Dong 4
4 · UroGen Pharma Ltd. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Kim Dong
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-09-09+2,500→ 37,753 total - Exercise/Conversion
Restricted Stock Units
2024-09-09−2,500→ 5,000 total→ Ordinary Shares (2,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The reporting person was granted RSUs on September 7, 2023 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.